Phase 0 Evaluation of [18F]MNI-958 as a Potential PET Radioligand for Imaging Tau Protein in the Brain

Clinical trial NCT03058965 · COMPLETED

Trial details

NCT number: NCT03058965
Sponsor: Molecular NeuroImaging
Status: COMPLETED
Phase: Early Phase 1
Study type: INTERVENTIONAL

Alzheimer Disease Healthy Volunteers Progressive Supranuclear Palsy

Start date: 2016-11-29
Primary completion: 2018-05-11
Enrollment: 12

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.